» Articles » PMID: 35970847

Efficacy and Safety of Deep Brain Stimulation for Treatment-refractory Anorexia Nervosa: a Systematic Review and Meta-analysis

Overview
Date 2022 Aug 15
PMID 35970847
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several pioneering studies investigated deep brain stimulation (DBS) in treatment-refractory anorexia nervosa (AN) patients, but overall effects remain yet unclear. Aim of this study was to obtain estimates of efficacy of DBS in AN-patients using meta-analysis.

Methods: We searched three electronic databases until 1st of November 2021, using terms related to DBS and AN. We included trials that investigated the clinical effects of DBS in AN-patients. We obtained data including psychiatric comorbidities, medication use, DBS target, and study duration. Primary outcome was Body Mass Index (BMI), secondary outcome was quality of life, and the severity of psychiatric symptoms, including eating disorder, obsessive-compulsive, depressive, and anxiety symptoms. We assessed the risk of bias using the ROBINS-I tool.

Results: Four studies were included for meta-analysis, with a total of 56 patients with treatment-refractory AN. Follow-up ranged from 6-24 months. Random effects meta-analysis showed a significant increase in BMI following DBS, with a large effect size (Hedges's g = 1 ∙ 13; 95% CI = 0 ∙ 80 to 1 ∙ 46; Z-value = 6 ∙ 75; P < 0 ∙ 001), without heterogeneity (I= 0 ∙ 00, P = 0 ∙ 901). Random effects meta-analysis also showed a significant increase in quality of life (Hedges's g = 0 ∙ 86; 95% CI = 0 ∙ 44 to 1 ∙ 28; Z-value = 4 ∙ 01, P < 0 ∙ 001). Furthermore, DBS decreased the severity of psychiatric symptoms (Hedges's g = 0 ∙ 89; 95% CI = 0 ∙ 57 to 1 ∙ 21; Z-value = 5 ∙ 47; P < 0 ∙ 001, I= 4 ∙ 29, P = 0 ∙ 371).

Discussion: In this first meta-analysis, DBS showed statistically large beneficial effects on weight restoration, quality of life, and reduction of psychiatric symptoms in patients with treatment-refractory AN. These outcomes call for more extensive naturalistic studies to determine the clinical relevance for functional recovery. This study is preregistered in PROSPERO,CRD42022295712.

Citing Articles

Biomarkers: The Key to Enhancing Deep Brain Stimulation Treatment for Psychiatric Conditions.

Bazarra Castro G, Casitas V, Martinez Macho C, Madero Pohlen A, Alvarez-Salas A, Barbero Pablos E Brain Sci. 2024; 14(11).

PMID: 39595828 PMC: 11592218. DOI: 10.3390/brainsci14111065.


Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa.

Abellaneda-Perez K, Delgado-Martinez I, Salgado P, Gines J, Guardiola R, Vaque-Alcazar L Acta Neurochir (Wien). 2024; 166(1):364.

PMID: 39261306 DOI: 10.1007/s00701-024-06258-w.


Neuromodulation of Eating Disorders: A Review of Underlying Neural Network Activity and Neuromodulatory Treatments.

Wu K, Lo Y, Cavaleri J, Bergosh M, Ipe J, Briggs R Brain Sci. 2024; 14(3).

PMID: 38539589 PMC: 10968923. DOI: 10.3390/brainsci14030200.


Established and emerging treatments for eating disorders.

Bryson C, Douglas D, Schmidt U Trends Mol Med. 2024; 30(4):392-402.

PMID: 38503683 PMC: 11439865. DOI: 10.1016/j.molmed.2024.02.009.


Neural effects of deep brain stimulation on reward and loss anticipation and food viewing in anorexia nervosa: a pilot study.

Oudijn M, Linders J, Lok A, Schuurman P, van den Munckhof P, van Elburg A J Eat Disord. 2023; 11(1):140.

PMID: 37605212 PMC: 10440869. DOI: 10.1186/s40337-023-00863-3.


References
1.
van Hoeken D, Hoek H . Review of the burden of eating disorders: mortality, disability, costs, quality of life, and family burden. Curr Opin Psychiatry. 2020; 33(6):521-527. PMC: 7575017. DOI: 10.1097/YCO.0000000000000641. View

2.
Barbier J, Gabriels L, Van Laere K, Nuttin B . Successful anterior capsulotomy in comorbid anorexia nervosa and obsessive-compulsive disorder: case report. Neurosurgery. 2011; 69(3):E745-51. DOI: 10.1227/NEU.0b013e31821964d2. View

3.
Goodman W, Price L, Rasmussen S, Mazure C, Fleischmann R, Hill C . The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989; 46(11):1006-11. DOI: 10.1001/archpsyc.1989.01810110048007. View

4.
Lipsman N, Lam E, Volpini M, Sutandar K, Twose R, Giacobbe P . Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry. 2017; 4(4):285-294. DOI: 10.1016/S2215-0366(17)30076-7. View

5.
Bewernick B, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B . Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2009; 67(2):110-6. DOI: 10.1016/j.biopsych.2009.09.013. View